Ready to play
Ready to play
Studies on mice have shown that the psychedelic substance psilocybin can prevent nerve damage associated with chemotherapy and preserve peripheral nerve function without reducing the effectiveness of cancer treatment. The results indicated that two doses of psilocybin administered before chemotherapy decrease sensitivity to cold, protect nerve endings, and maintain the sense of touch, in addition to safeguarding the mitochondria in nerve cells from damage caused by the treatment drugs. Clinical trials will be conducted with patients to confirm psilocybin's effectiveness in reducing chemotherapy-induced peripheral neuropathy, with the aim of providing a treatment that prevents nerve damage without compromising cancer therapy.
Notice: This Is an AI-Generated Summary
Comments (0)